DE69413606D1 - Endothelinantagonistische Peptide - Google Patents

Endothelinantagonistische Peptide

Info

Publication number
DE69413606D1
DE69413606D1 DE69413606T DE69413606T DE69413606D1 DE 69413606 D1 DE69413606 D1 DE 69413606D1 DE 69413606 T DE69413606 T DE 69413606T DE 69413606 T DE69413606 T DE 69413606T DE 69413606 D1 DE69413606 D1 DE 69413606D1
Authority
DE
Germany
Prior art keywords
antagonistic peptides
endothelin antagonistic
endothelin
peptides
antagonistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413606T
Other languages
English (en)
Other versions
DE69413606T2 (de
Inventor
Kiyofumi Ishikawa
Takehiro Fukami
Masaki Ihara
Mitsuo Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Application granted granted Critical
Publication of DE69413606D1 publication Critical patent/DE69413606D1/de
Publication of DE69413606T2 publication Critical patent/DE69413606T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69413606T 1993-06-03 1994-06-01 Endothelinantagonistische Peptide Expired - Fee Related DE69413606T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15790793 1993-06-03

Publications (2)

Publication Number Publication Date
DE69413606D1 true DE69413606D1 (de) 1998-11-05
DE69413606T2 DE69413606T2 (de) 1999-04-15

Family

ID=15660055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413606T Expired - Fee Related DE69413606T2 (de) 1993-06-03 1994-06-01 Endothelinantagonistische Peptide

Country Status (5)

Country Link
US (1) US5494897A (de)
EP (1) EP0632052B1 (de)
AU (1) AU673731B2 (de)
CA (1) CA2124989A1 (de)
DE (1) DE69413606T2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430022A (en) * 1990-05-14 1995-07-04 Fujisawa Pharmaceutical Co., Ltd. Peptide compound and its preparation
US5614497A (en) * 1991-12-27 1997-03-25 Takeda Chemical Industries, Ltd. Peptide, production and use thereof
PT1165613E (pt) 1999-03-29 2008-07-29 Procter & Gamble Ligantes do receptor de melanocortina
FR2913978B1 (fr) * 2007-03-21 2009-07-03 Centre Nat Rech Scient Procede de synthese de peptides sans solvant
US9822157B2 (en) 2013-03-15 2017-11-21 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
DK3143037T3 (da) 2014-05-16 2021-09-20 Protagonist Therapeutics Inc Alpha4beta7-integrin-thioether-peptidantagonister
EP3169403B1 (de) 2014-07-17 2024-02-14 Protagonist Therapeutics, Inc. Orale peptidinhibitoren des interleukin-23-rezeptors und deren verwendung zur behandlung von entzündlichen darmerkrankungen
SG11201702553RA (en) 2014-10-01 2017-04-27 Protagonist Therapeutics Inc NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US20190002503A1 (en) 2015-12-30 2019-01-03 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
US11753443B2 (en) 2018-02-08 2023-09-12 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
JP2021530477A (ja) * 2018-07-12 2021-11-11 プロタゴニスト セラピューティクス， インコーポレイテッド インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用
CN114341161A (zh) 2019-07-10 2022-04-12 领导医疗有限公司 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
JP7441955B2 (ja) 2020-01-15 2024-03-01 ヤンセン バイオテツク，インコーポレーテツド インターロイキン２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用
MX2023005994A (es) 2020-11-20 2023-08-11 Janssen Pharmaceutica Nv Composiciones de inhibidores peptidicos del receptor de interleucina-23.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
US5144918A (en) * 1990-07-19 1992-09-08 Mazda Motor Corporation Intake system for engine
GB9300048D0 (en) * 1993-01-04 1993-03-03 Wellcome Found Endothelin converting enzyme inhibitors

Also Published As

Publication number Publication date
AU673731B2 (en) 1996-11-21
DE69413606T2 (de) 1999-04-15
EP0632052B1 (de) 1998-09-30
EP0632052A1 (de) 1995-01-04
AU6345494A (en) 1994-12-22
CA2124989A1 (en) 1994-12-04
US5494897A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
DE4393381T1 (de) Peptide
DE69129395T2 (de) Antimikrobielle Peptide
DK6893D0 (da) Peptid
DE69332485D1 (de) Immunmodulierende peptide
NO942066L (no) Peptidderivater
NO943190D0 (no) Sulfonamid-endothelin-antagonister
LV10962A (lv) Jauni peptidi
DE69413606D1 (de) Endothelinantagonistische Peptide
DE69433229D1 (de) ATM-Schalter
NO976058L (no) Rekombinant mistellectin
FI940109A0 (fi) Peptidejä
DE69931010D1 (de) Peptide mit osteogener Aktivität
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
DE69425205T2 (de) Aminofunktionelle Polyester
BR9306138A (pt) Peptídeos antivirais
DE69232771D1 (de) Peptide als antagonisten von endothelin
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
NO932237D0 (no) Lineaere peptider
ATE277076T1 (de) Antineoplastische peptide
DE69420044D1 (de) Blutregulierende peptide
NO955059D0 (no) Peptider som utviser oksytocin antagonistisk aktivitet
DE68914057D1 (de) Peptide.
NO962204D0 (no) Dobbeltkjedede hemoregulatoriske peptider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee